AW
CKPT

ACG Wealth’s Checkpoint Therapeutics CKPT Stock Holding History

ACG Wealth’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12K Hold
1,200
– – ﹤0.01% 245
2022
Q2 		$12K Hold
1,200
– – ﹤0.01% 664
2022
Q1 		$21K Buy
+1,200
New +$25.8K ﹤0.01% 278

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

ACG Wealth's CKPT Position: Q3 2022 in Review

ACG Wealth held its Checkpoint Therapeutics (CKPT) position steady in Q3 2022 at 1,200 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #245.

ACG Wealth first reported a position in CKPT in Q1 2022 and has held it in 3 quarters since. The position peaked at $21K in Q1 2022. 57 funds tracked by Wall St. Rank hold CKPT as of Q3 2022.

  • ACG Wealth held 1,200 shares of Checkpoint Therapeutics worth $12K as of Q3 2022.
  • ACG Wealth left its Checkpoint Therapeutics share count unchanged in Q3 2022.
  • Checkpoint Therapeutics made up ﹤0.01% of ACG Wealth's portfolio in Q3 2022, its #245 holding.
  • ACG Wealth first reported a position in Checkpoint Therapeutics in Q1 2022 and has held it in 3 quarters since.
  • ACG Wealth's Checkpoint Therapeutics position peaked at $21K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.